Lancet COVID-19 Hydroxychloroquine Study Faces 'Data Integrity' Questions
By Michael O'Riordan
Hydroxychloroquine prescriptions surged 2,000% in March when Trump touted malaria drug
By Berkeley Lovelace & Berkeley Lovelace Jr.
Scientists Question Major Hydroxychloroquine Study
By Roni Caryn Rabin
France Bars Use Of Hydroxychloroquine In COVID-19 Cases
By Bill Chappell